Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 4, 2012, Pages 543-551

  Aeffner, Famke ^a   Bratasz, Anna ^a   Flaño, Emilio ^b   Powell, Kimerly A ^a   Davis, Ian C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Alveolar fluid clearance; Antiviral agents; ARDS; Lung function; Pulmonary edema

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 6; TERIFLUNOMIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY FUNCTION; HEART FUNCTION; INFLUENZA A (H1N1); LUNG FLUID; LUNG LAVAGE; LUNG MECHANICS; LUNG VOLUME; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSCILLATION; OXYGENATION; PULSE OXIMETRY; VIRUS REPLICATION; WATER CONTENT;

ADMINISTRATION, INHALATION; AIRWAY RESISTANCE; ANILINE COMPOUNDS; ANIMALS; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CAROTID ARTERIES; CYTOKINES; DRUG EVALUATION, PRECLINICAL; HEART RATE; HYDROXYBUTYRATES; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; OXYGEN; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY RATE; VIRUS REPLICATION;

MUS;

EID: 84866990781     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0112OC     Document Type: Article

References (50)

1. Clark N, Lynch J. Influenza: epidemiology, clinical features, therapy, and prevention. Semin Respir Crit Care Med 2011;32:373-392.
2. Hamilton BE, Miniño AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 2007;119:345-360. (Pubitemid 46397761)
3. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010;28:4895-4902.
4. Fedson DS. Preparing for pandemic vaccination: an international policy agenda for vaccine development. J Public Health Policy 2005;26:4-29. (Pubitemid 40632275)
5. Gregory A. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010;28:D3-D13.
6. Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis 2011;43:683-689.
7. Fedson DS, Dunnill P. Commentary: from scarcity to abundance: pandemic vaccines and other agents for "have not" countries. J Public Health Policy 2007;28:322-340.
8. Thorlund K, Awad T, Boivin G, Thabane L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis 2011;11:134.
9. Dimitrov NB, Goll S, Hupert N, Pourbohloul B, Meyers LA. Optimizing tactics for use of the US antiviral strategic national stockpile for pandemic influenza. PLoS ONE 2011;6:e16094.
10. Cochrane Neuraminidase Inhibitors Review Team. Does oseltamivir really reduce complications of influenza? Clin Infect Dis 2011;53:1302-1303.
11. Li G, Yilmaz M, Kojicic M, Fernandez-Perez E, Wahab R, Huskins WC, Afessa B, Truwit JD, Gajic O. Outcome of critically ill patients with influenza virus infection. J Clin Virol 2009;46:275-278.
12. Westall G, Paraskeva M. H1N1 influenza: critical care aspects. Semin Respir Crit Care Med 2011;32:400-408.
13. Higgins AM, Pettila V, Harris AH, Bailey M, Lipman J, Seppelt IM,Webb SA. The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand. Anaesth Intensive Care 2011;39:384-391.
14. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005;352:1839-1842. (Pubitemid 40627807)
15. Wolk KE, Lazarowski ER, Traylor ZP, Yu EN, Jewell NA, Durbin RK, Durbin JE, Davis IC. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med 2008;178:969-976.
16. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82:569-600. (Pubitemid 34743332)
17. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-1383. (Pubitemid 32506602)
18. Martin SS, Hollingsworth CL, Norfolk SG, Wolfe CR, Hollingsworth JW. Reversible cardiac dysfunction associated with pandemic 2009 influenza A (H1N1). Chest 2010;137:1195-1197.
19. Wiegand JA, Torgersen C, Bloechlinger S, Takala J, Dunser MW. Influenza A (H1N1) infection and severe cardiac dysfunction in adults: a case series. Wien Klin Wochenschr 2011;123:120-123.
20. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European Consensus Conference on Acute Respiratory Distress Syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination: Consensus Committee. J Crit Care 1994;9:72-81. (Pubitemid 24095051)
21. Ferguson ND, Davis AM, Slutsky AS, Stewart TE. Development of a clinical definition for acute respiratory distress syndrome using the Delphi technique. J Crit Care 2005;20:147-154. (Pubitemid 41219635)
22. Schuster DP, Kovacs A, Garbow J, Piwnica-Worms D. Recent advances in imaging the lungs of intact small animals. Am J Respir Cell Mol Biol 2004;30:129-138. (Pubitemid 38152965)
23. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L152-L161.
24. Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, Russo S, Patroniti N, Cornejo R, Bugedo G. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006;354:1775-1786.
25. Karmrodt J, Bletz C, Yuan S, David M, Heussel CP, Markstaller K. Quantification of atelectatic lung volumes in two different porcine models of ARDS. Br J Anaesth 2006;97:883-895. (Pubitemid 44823680)
26. Estenssoro E, Rios FG, Apezteguia C, Reina R, Neira J, Ceraso DH, Orlandi C, Valentini R, Tiribelli N, Brizuela M, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010;182:41-48.
27. Sessler CN, Gray ND. Intensive care management of life-threatening avian influenza A (H5N1). Respirology 2008;13(Suppl 1):S27-S32. (Pubitemid 351661392)
28. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008;3:499-522. (Pubitemid 351488291)
29. Smetanin P, Stiff D, Kumar A, Kobak P, Zarychanski R, Simonsen N, Plummer F. Potential intensive care unit ventilator demand/capacity mismatch due to novel swine-origin H1N1 in Canada. Can J Infect Dis Med Microbiol 2009;20:e115-e123.
30. Lum ME, McMillan AJ, Brook CW, Lester R, Piers LS. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust 2009;191:502-506.
31. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM, on behalf of the Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011;44:725-738.
32. 2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or ARDS. Chest 2007;132:410-417.
33. Hatta Y, Hershberger K, Shinya K, Proll SC, Dubielzig RR, Hatta M, Katze MG, Kawaoka Y, Suresh M. Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice. PLoS Pathog 2010;6:e1001139.
34. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, Garcia-Sastre A, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006;443:578-581. (Pubitemid 44527293)
35. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007;104:12479-12481. (Pubitemid 47206163)
36. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MBA, Rosen H. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011;146:980-991.
37. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008;4:e1000115.
38. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009;106:3455-3460.
39. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, van Rooijen N, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005;79:14933-14944. (Pubitemid 41636290)
40. Maniatis NA, Orfanos SE. The endothelium in acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2008;14:22-30.
41. Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci USA 2011;108:5777-5782.
42. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.
43. Perrone LA, Szretter K, Katz J, Mizgerd J, Tumpey T. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis 2010;202:1161-1170.
44. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005;33:1-6. (Pubitemid 40116529)
45. Wolters PJ, Wray C, Sutherland RE, Kim SS, Koff J, Mao Y, Frank JA. Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol 2009;182:8056-8062.
46. Kolliputi N, Waxman AB. IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation. Am J Physiol Lung Cell Mol Physiol 2009;297:L6-L16.
47. Dienz O, Rud JG, Eaton SM, Lanthier PA, Burg E, Drew A, Bunn J, Suratt BT, Haynes L, Rincon M. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol 2012;5:258-266.
48. Wang S, Le T, Kurihara N, Chida J, Cisse Y, Yano M, Kido H. Influenza virus cytokine protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis 2010;202:991-1001.
49. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996;93:2448-2453. (Pubitemid 26104370)
50. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, Reading PC. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 2009;183:7441-7450.